Hormones and creatine: what is the link?

The question is almost always asked backward. People ask what creatine does to hormones, when the documented relationship goes the other way: it is estrogen and progesterone that influence how the body makes, transports, and stores creatine.

What creatine does not do

Let’s start by clearing up the misunderstanding, because it is widespread and it sells.

Creatine is not a hormone. It does not stimulate their production, compensate for their decline, or interact with hormone therapy. It is neither a phytoestrogen nor an endocrine disruptor.

It is an energy transfer molecule, 95% of which is stored in muscle, whose role is to recycle ATP during short, intense efforts. No European health claim links it to hormones, menopause, mood, or sleep — and nothing in this article claims otherwise.

It is not hormones that follow creatine. It is creatine that follows hormones.

What hormones do to creatine

This is where it gets interesting, and this is the direction documented by research.

Creatine is synthesized in two steps by enzymes present in the kidneys and liver, then transported to the muscle by a specific transporter. Several of these players are sensitive to sex steroids: studies conducted on women show that estrogen and progesterone influence the expression and activity of these enzymes, as well as the transport of creatine into muscle¹.

In other words, hormonal status is one of the variables that determine how much creatine is in a muscle at any given time.

This is one explanation for the initial observation: muscle creatine concentrations in women are 70 to 80% lower than in men¹. Muscle mass and dietary intake explain part of the gap; the hormonal context explains another.

Variations during the cycle

Creatine concentrations and the activity of creatine kinase — the enzyme that mobilizes it in the muscle — are not stable throughout the menstrual cycle¹.

This point should be taken with caution. Studies are few in number, sample sizes are modest, and measurement methods are heterogeneous. Variations are observed; it is not yet known what they imply in practice.

What is reasonable to take away: there are no validated recommendations to adjust intake based on the cycle phase. The protocols used in trials rely on constant daily intake.

What changes during perimenopause

The menopausal transition changes the hormonal context in a lasting, rather than cyclical, way.

The decline in estrogen is accompanied by a faster loss of muscle mass and strength. This is an established mechanism, independent of any supplementation.

Yet muscle is precisely where creatine is stored. Less muscle mass means a lower storage capacity, which shifts the question: it is no longer a matter of whether creatine acts on hormones, but of noting that the tissue in question changes at this stage of life.

It is this convergence — a changing hormonal context, weakening tissue, and a metabolism sensitive to both — that explains why research has begun to study creatine specifically in women, at every stage of life.

The documented protocols rely on 3 to 5 g per day of creatine monohydrate, taken regularly every day, regardless of cycle phase or hormonal status². There is no "hormone-adapted" dosage, and no one has demonstrated the benefit of making an adjustment.

The variable that counts remains consistency: muscle stores fill up in three to four weeks of continuous intake and drop back down a few weeks after stopping.

What should be left to a doctor

If you are on hormone replacement therapy for menopause, or if you are considering starting one, the question should be discussed with them — not because creatine would interfere, but because they are the right person to integrate a supplement into a comprehensive care plan.

Significant symptoms — unusual loss of strength, persistent fatigue, established sleep disturbances — merit a check-up, not an adjustment via dietary supplement.

To go further: creatine and menopause · creatine for women · the 19 most frequently asked questions